Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Robert Wessel

Orthopaedic Trauma Allentown, PA Medical Doctor

NPI 1437564556 CMS profile 1824612

1250 S Cedar Crest Blvd Ste 110, Allentown, PA 18103

Open in the dashboard

General payments

$26,551

176 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Robert Wessel of Allentown, PA is reported in the CMS Open Payments database as having received $26,551 across 176 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 71st percentile of Orthopaedic Trauma profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $13,523 68
2024 General $5,142 22
2023 General $4,169 33
2022 General $906 12
2021 General $517 9
2020 General $268 11
2019 General $2,027 21

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Wessel
  • Orthopaedic Trauma median
  • Middle half of Orthopaedic Trauma
  • National median

In program year 2025, general payments to Robert Wessel were reported at $13,523. Among 734 Orthopaedic Trauma profiles paid that year, the median was $1,227 and the middle half received between $259 and $7,433.

Show as a table
Year Robert Wessel Orthopaedic Trauma median Middle half National median
2019 $2,027 $1,475 $264–$6,401 $163
2020 $268 $596 $120–$4,020 $114
2021 $517 $919 $171–$4,697 $132
2022 $906 $1,547 $272–$7,240 $149
2023 $4,169 $1,330 $247–$5,875 $160
2024 $5,142 $1,288 $277–$6,797 $164
2025 $13,523 $1,227 $259–$7,433 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $15,639 48 payments
  2. Stryker Corporation $4,743 62 payments
  3. Novus Surgical Consultants $2,439 21 payments
  4. Medical Device Business Services, Inc. $1,388 10 payments
  5. SI-BONE, Inc. $554 5 payments
  6. DePuy Synthes Sales Inc. $434 9 payments
  7. Kerecis Limited $369 3 payments
  8. Sanara MedTech Inc. $247 3 payments
  9. Skeletal Dynamics Inc $197 3 payments
  10. Zimmer Biomet Holdings, Inc. $109 1 payment
  11. Other $432 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,250 5 payments
  2. Food and Beverage $8,121 147 payments
  3. Travel and Lodging $6,592 21 payments
  4. Education $338 2 payments
  5. Grant $250 1 payment
Products named General payments · program years 2019–2025
  1. PELVIS II $897 11 payments
  2. PRO $811 2 payments
  3. T2 ALPHA $553 8 payments
  4. VARIAX $534 6 payments
  5. AXSOS $503 3 payments
  6. GAMMA Trauma & Extremeties $491 2 payments
  7. HOFFMANN $489 2 payments
  8. GAMMA Trauma & Extremeties $484 7 payments
  9. T2 Trauma & Extremeties $482 1 payment
  10. T2 Trauma & Extremeties $392 5 payments
  11. Other $6,095 92 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

13

Median for Orthopedic Surgery: 203

Drug cost

$54

Median for Orthopedic Surgery: $1,433

Branded share of claims

0%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone Hcl Generic 13 $54

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 137 billing codes

Paid by Medicare

$203,130

Of which drugs: $674

Medicare patients

411

Average age 78

Services billed

1,181

288 women, 123 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 71%
Depression 47%
Osteoporosis 47%
Chronic kidney disease 44%
Diabetes 39%
Ischemic heart disease 39%
Atrial fibrillation 36%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 12 96 $73

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

176 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Trauma in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record